/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Chelsea Gohd

Chelsea Gohd

Staff Writer

Latest Stories

Futurism
1.29.17, 4:17 PM EST on futurism
Apple joins Amazon, Facebook, Google, IBM and Microsoft in AI initiative
Futurism
1.28.17, 7:28 PM EST on futurism
Companies Aiming for 2020 Launch of Commercial ISS Replacement
Futurism
1.27.17, 1:47 PM EST on futurism
AI Can Identify Skin Cancer As Well As Doctors
Futurism
1.27.17, 12:49 PM EST on futurism
One Man Rode 900 Miles Across the UK...In Virtual Reality
Futurism
1.27.17, 12:31 PM EST on futurism
China Set to Release the World's Fastest Computer
Futurism
1.27.17, 10:40 AM EST on futurism
Scientists Move Closer to Creating the First "Human/Pig Chimera"
Futurism
1.26.17, 1:25 PM EST on neoscope
Genetically Modified Cells Just Cured Two Babies of Leukemia
Futurism
1.26.17, 12:00 PM EST on futurism
Tesla's Set to Launch the World's Largest Energy Storage Project
Futurism
1.25.17, 11:46 AM EST on futurism
Scientists Are Making a Fabric of "Biological Tissues"
Futurism
1.24.17, 2:25 PM EST on futurism
Tesla Aims to Eliminate 90% of Crashes
Futurism
1.24.17, 2:22 PM EST on futurism
First-Ever Semi-Synthetic Organism Opens The Door to New Forms of Life
Futurism
Updated 1.24.17, 10:16 AM EST on futurism
New Evidence Confirms That Microorganisms Can Survive on Mars
  • Previous
  • 1
  • ...
  • 47
  • 48
  • 49
  • 50
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.